المؤلفون: Abdel-Rahman O; Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. omar.abdelsalam@ahs.ca.; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, T2N4N1, Canada. omar.abdelsalam@ahs.ca., Ahmed O; Department of Oncology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

المصدر: International journal of colorectal disease [Int J Colorectal Dis] 2019 Apr; Vol. 34 (4), pp. 675-680. Date of Electronic Publication: 2019 Jan 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8607899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1262 (Electronic) Linking ISSN: 01791958 NLM ISO Abbreviation: Int J Colorectal Dis

مواضيع طبية MeSH: Hospitalization* , Randomized Controlled Trials as Topic*, Colorectal Neoplasms/*drug therapy , Colorectal Neoplasms/*pathology , Fluorouracil/*adverse effects , Fluorouracil/*therapeutic use, Cohort Studies ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Metastasis ; Survival Analysis

المؤلفون: Akdeniz, Nadiye, Kaplan, Muhammet Ali, Uncu, Doğan, İnanç, Mevlüde, Kaya, Serap, Dane, Faysal, Küçüköner, Mehmet, Demirci, Ayşe, Bilici, Mehmet, Durnalı, Ayşe Gök, Koral, Lokman, Şendur, Mehmet Ali Nahit, Erol, Cihan, Türkmen, Esma, Ölmez, Ömer Fatih, Açıkgöz, Özgür, Laçin, Şahin, Şahinli, Hayriye, Urakçı, Zuhat, Işıkdoğan, Abdurrahman

المصدر: International Journal of Colorectal Disease; Jun2021, Vol. 36 Issue 6, p1311-1319, 9p

مصطلحات موضوعية: ADJUVANT treatment of cancer, ANTINEOPLASTIC combined chemotherapy protocols, COLORECTAL cancer, OVERALL survival, FLUOROURACIL

المؤلفون: Landre T; Unité de Coordination en Onco-Gériatrie UCOG 93, APHP, René Muret Hospital, HUPSSD - Université Paris 13, Sevran, France. thierry.landre@rmb.aphp.fr.; Department of Geriatric Oncology, APHP, René Muret Hospital, HUPSSD, Sevran, France. thierry.landre@rmb.aphp.fr., Uzzan B; Department of Pharmacology, APHP, Avicenne Hospital, HUPSSD, Bobigny, France., Nicolas P; Department of Pharmacology, APHP, Avicenne Hospital, HUPSSD, Bobigny, France., Aparicio T; Department of Gastroenterology and Digestive Oncology, APHP, Avicenne Hospital, HUPSSD, Université Paris 13, Sorbonne-Paris Cité, France., Zelek L; Department of Clinical Oncology, APHP, Avicenne Hospital, HUPSSD, Bobigny, France., Mary F; Department of Gastroenterology and Digestive Oncology, APHP, Avicenne Hospital, HUPSSD, Université Paris 13, Sorbonne-Paris Cité, France., Taleb C; Unité de Coordination en Onco-Gériatrie UCOG 93, APHP, René Muret Hospital, HUPSSD - Université Paris 13, Sevran, France.; Department of Geriatric Oncology, APHP, René Muret Hospital, HUPSSD, Sevran, France., Des Guetz G; Unité de Coordination en Onco-Gériatrie UCOG 93, APHP, René Muret Hospital, HUPSSD - Université Paris 13, Sevran, France.; Department of Clinical Oncology, APHP, Avicenne Hospital, HUPSSD, Bobigny, France.

المصدر: International journal of colorectal disease [Int J Colorectal Dis] 2015 Oct; Vol. 30 (10), pp. 1305-10. Date of Electronic Publication: 2015 Jun 23.

نوع المنشور: Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8607899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1262 (Electronic) Linking ISSN: 01791958 NLM ISO Abbreviation: Int J Colorectal Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Colorectal Neoplasms/*drug therapy , Fluorouracil/*therapeutic use, Aged ; Antineoplastic Agents, Phytogenic/adverse effects ; Antineoplastic Agents, Phytogenic/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Camptothecin/adverse effects ; Camptothecin/analogs & derivatives ; Camptothecin/therapeutic use ; Clinical Trials, Phase III as Topic ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/secondary ; Disease Progression ; Humans ; Irinotecan ; Organoplatinum Compounds/adverse effects ; Organoplatinum Compounds/therapeutic use ; Oxaliplatin

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.